Exact Mass: 405.236255

Icacine

UCL 1608

C30H31N (405.2456366)

Astromicin

Fortimicin A

An amino cyclitol glycoside that is L-chiro-inositol in which the hydroxy groups at positions 1, 4, and 6 are replaced by aminoacetyl)methylamino, amino, and methoxy groups, respectively, and in which the hydroxy group at position 3 is converted to the corresponding 2,6-diamino-2,3,4,6,7-pentadeoxy-beta-L-lyxo-heptopyranoside. The major component of fortimicin, obtained from Micromonospora olivasterospora. It is administered (as the sulfate salt) by intramuscular injection or intravenous infusion for the treatment of severe systemic infections due to sensitive Gram-negative organisms. C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic

3-Deoxo-4b-deoxypaxilline

12-Demethyl-11,12-dehydropaspaline

Lisinopril

N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline

C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D020011 - Protective Agents > D002316 - Cardiotonic Agents COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Lisinopril (MK-521) is angiotensin-converting enzyme inhibitor, used in treatment of hypertension, congestive heart failure, and heart attacks.

Lisinopril

(2S)-1-[(2S)-6-amino-2-{[(1S)-1-carboxy-3-phenylpropyl]amino}hexanoyl]pyrrolidine-2-carboxylic acid

One of the Angiotensin-converting enzyme inhibitors (ACE inhibitors), orally active, that has been used in the treatment of hypertension and congestive heart failure. -- Pubchem; Lisinopril is a drug of the angiotensin converting enzyme (ACE) inhibitor class that is primarily used in treatment of hypertension, congestive heart failure and heart attacks. Historically, lisinopril was the third ACE inhibitor, after captopril and enalapril that was introduced into therapy in early 1990s . Lisinopril has a number of properties that distinguish it from other ACE inhibitors: it is hydrophilic, has long half life and tissue penetration and is not metabolized by the liver. -- Wikipedia; Lisinopril is solely excreted in urine in the unchanged form. Elimination of the drug depends on glomerular filtration and tubular excretion. Rate of lisinopril elimination decreases with old age and kidney or heart failure. There is a relation between creatinine and lisinopril clearance. With prolonged therapy dose reduction can be necessary to avoid accumulation. -- Wikipedia [HMDB] One of the Angiotensin-converting enzyme inhibitors (ACE inhibitors), orally active, that has been used in the treatment of hypertension and congestive heart failure. -- Pubchem; Lisinopril is a drug of the angiotensin converting enzyme (ACE) inhibitor class that is primarily used in treatment of hypertension, congestive heart failure and heart attacks. Historically, lisinopril was the third ACE inhibitor, after captopril and enalapril that was introduced into therapy in early 1990s. Lisinopril has a number of properties that distinguish it from other ACE inhibitors: it is hydrophilic, has long half life and tissue penetration and is not metabolized by the liver. -- Wikipedia; Lisinopril is solely excreted in urine in the unchanged form. Elimination of the drug depends on glomerular filtration and tubular excretion. Rate of lisinopril elimination decreases with old age and kidney or heart failure. There is a relation between creatinine and lisinopril clearance. With prolonged therapy dose reduction can be necessary to avoid accumulation. -- Wikipedia.

Imidapril

(4S)-1-Methyl-3-[(2S)-2-[N-((1S)-1-ethoxycarbonyl-3-phenylpropyl)amino]propionyl]-2-oxo-imidazolidine-4-carboxylic acid

Imidapril, also known as Tanatril (trade name), belongs to a class of long-acting, non-sulfhydryl angiotensin-converting enzyme (ACE) inhibitors (PMID: 12177688). It is a prodrug that is widely used in the treatment of mild to moderate essential hypertension (PMID: 17547476). A prodrug is a drug that must be metabolized in the body (via the gut or the liver) to become active. Imidapril is also prescribed to treat chronic congestive heart failure (CHF), acute myocardial infarction (AMI), and diabetic nephropathy (PMID: 12177688, 17094051). It functions through preventing angiotensin II formation, via inhibition of the angiotensin-converting enzyme (ACE), that results in reduction of peripheral resistance and a reduction in systemic blood pressure (BP) (PMID: 17547476). Imidapril is only found in individuals that have used or taken this drug. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

N-Eicosapentaenoyl Cysteine

2-(icosa-5,8,11,14,17-pentaenamido)-3-sulfanylpropanoic acid

N-eicosapentaenoyl cysteine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Eicosapentaenoic acid amide of Cysteine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Eicosapentaenoyl Cysteine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Eicosapentaenoyl Cysteine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

4-Oxofenretinide

N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl)nona-2,4,6,8-tetraenamide

Astromicin

2-amino-N-(4-amino-3-{[3-amino-6-(1-aminoethyl)oxan-2-yl]oxy}-2,5-dihydroxy-6-methoxycyclohexyl)-N-methylacetamide

Cypridina luciferin

N-{3-[2-(butan-2-yl)-3-hydroxy-6-(1H-indol-3-yl)imidazo[1,2-a]pyrazin-8-yl]propyl}guanidine

Febarbamate

{[1-butoxy-3-(5-ethyl-4-hydroxy-2,6-dioxo-5-phenyl-1,2,5,6-tetrahydropyrimidin-1-yl)propan-2-yl]oxy}carboximidic acid

M - Musculo-skeletal system > M03 - Muscle relaxants > M03B - Muscle relaxants, centrally acting agents > M03BA - Carbamic acid esters C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent

N-(4-Methoxyphenyl)-all-trans-retinamide

N-(4-methoxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenamide

Nifekalant

6-({2-[(2-hydroxyethyl)[3-(4-nitrophenyl)propyl]amino]ethyl}imino)-1,3-dimethyl-2-oxo-1,2,3,6-tetrahydropyrimidin-1-ium-4-olate

C19H27N5O5 (405.2012092)

D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents

Terbogrel

6-[3-(N-tert-butyl-N-cyanocarbamimidamido)phenyl]-6-(pyridin-3-yl)hex-5-enoic acid

trequinsin

2,3,6,7-Tetrahydro-9,10-dimethoxy-3-methyl-2-((2,4,6-trimethylphenyl)imino)-4H-pyrimido(6,1-a)isoquinolin-4-one, monohydrochloride

D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor

3-[2-(1,1-dimethyl-allyl)-5-(3,3-dimethyl-oxiranylmethyl)-indol-3-ylmethylene]-6-methylene-piperazine-2,5-dione|Isoechinulin C|isoechinulin-C

Oxystemokerrin

Neotuberostemonone

Ancistrobrevine C

NSC682457

Farinosone A

Leuconine

Pentagynine

CHEMBL1413305

C22H31NO4S (405.19736860000006)

nifekalant

C19H27N5O5 (405.2012092)

C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents C93038 - Cation Channel Blocker

Gerambullin

(+/-)-celallocinnine|2-phenyl-9-(3-phenyl-acryloyl)-1,5,9-triaza-cyclotridecan-4-one|caesalpinine C|celallocinine|Celallocinnin|Celallocinnine

ancistrotanzanine A|ancistrotectorines D

C22H31NO4S (405.19736860000006)

Epothilone K

ent-Ircinialactam C

(+/-)-dihydroperiphylline|4-phenyl-9-(3-phenyl-acryloyl)-1,5,9-triaza-cyclotridecan-2-one|Dihydroperiphyllin|Dihydroperiphylline

1,2-didehydroancistrobertsonine D

ancistrotectoriline C

sessilifoliamide E

(E,E)-Maytenine|Maytenin (1)|maytenine|N1,N8-dicinnamoyl spermidine

akirine

(S)-Cypridina luciferin|Cypridina luciferin|[3-(2-sec-butyl-6-indol-3-yl-3-oxo-3,7-dihydro-imidazo[1,2-a]pyrazin-8-yl)-propyl]-guanidine|{3-[2((S)-sec-Butyl)-6-indol-3-yl-3-oxo-3,7-dihydro-imidazo[1,2-a]pyrazin-8-yl]-propyl}-guanidin|{3-[2((S)-sec-butyl)-6-indol-3-yl-3-oxo-3,7-dihydro-imidazo[1,2-a]pyrazin-8-yl]-propyl}-guanidine

(S)-Cypridina luciferin|Cypridina luciferin|[3-(2-sec-butyl-6-indol-3-yl-3-oxo-3,7-dihydro-imidazo[1,2-a]pyrazin-8-yl)-propyl]-guanidine|{3-[2((S)-sec-Butyl)-6-indol-3-yl-3-oxo-3,7-dihydro-imidazo[1,2-a]pyrazin-8-yl]-propyl}-guanidin|{3-[2((S)-sec-butyl)-6-indol-3-yl-3-oxo-3,7-dihydro-imidazo[1,2-a]pyrazin-8-yl]-propyl}-guanidine

14-dehydrotalatisamine

(S,3Z)-3-((1,7-dihydro-7,7-dimethyl-2-(2-methylbut-3-en-2-yl)pyrano[2,3-g]indol-3-yl)methylene)-6-methylpiperazine-2,5-dione|talathermophilin B

(+)-Halichlorine|chalichlorine|halichlorine

C23H32ClNO3 (405.2070592)

tuberostemonoxirine

stemona-amine B

22alpha,23alpha-epoxy-10-epi-solanida-1,4,9-trien-3-one

(S)-cypridina luciferin|cypridina luciferin

6-O-demethylancistroealaine A

17-hydroxydaphnigraciline

maireistemoninol

Fragilamide

SCHEMBL214410

Fortimicin KO

14-dehydrogenicunin B

daphlongamine D

His Ile His

Ile Phe Leu

Lys Arg Cys

Ile Leu Phe

Tyr Pro Leu

Leu Pro Tyr

Leu Phe Ile

methionyllysyllysine

His His Ile

C17H31N3O6S (405.19334660000004)

Glu Met Leu

Ile His His

Pro Leu Tyr

C17H31N3O6S (405.19334660000004)

Glu Leu Met

Phe Ile Leu

C17H31N3O6S (405.19334660000004)

Leu Met Glu

Pro Tyr Leu

Isoechinulin C

Lisinopril (Zestril)

Cypridinid luciferin

Febarbamate

[1-butoxy-3-(5-ethyl-2,4,6-trioxo-5-phenyl-1,3-diazinan-1-yl)propan-2-yl] carbamate

Imidapril

(4S)-3-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-1-methyl-2-oxoimidazolidine-4-carboxylic acid

Ala Gly Lys Met

(2S)-2-[(2S)-6-amino-2-{2-[(2S)-2-aminopropanamido]acetamido}hexanamido]-4-(methylsulfanyl)butanoic acid

Ala Gly Met Lys

(2S)-6-amino-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-4-(methylsulfanyl)butanamido]hexanoic acid

Ala Lys Gly Met

(2S)-2-{2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]acetamido}-4-(methylsulfanyl)butanoic acid

Ala Lys Met Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-4-(methylsulfanyl)butanamido]acetic acid

Ala Lys Ser Thr

(2S,3R)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

Ala Lys Thr Ser

(2S)-2-[(2S,3R)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

Ala Met Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-4-(methylsulfanyl)butanamido]acetamido}hexanoic acid

Ala Met Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-(methylsulfanyl)butanamido]hexanamido]acetic acid

Ala Ser Lys Thr

(2S,3R)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]hexanamido]-3-hydroxybutanoic acid

Ala Ser Thr Lys

(2S)-6-amino-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]hexanoic acid

Ala Thr Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]hexanamido]-3-hydroxypropanoic acid

Ala Thr Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]hexanoic acid

Cys Gly Lys Val

(2S)-2-[(2S)-6-amino-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}hexanamido]-3-methylbutanoic acid

Cys Gly Val Lys

(2S)-6-amino-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-methylbutanamido]hexanoic acid

Cys Lys Gly Val

(2S)-2-{2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]acetamido}-3-methylbutanoic acid

Cys Lys Val Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-methylbutanamido]acetic acid

Cys Val Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylbutanamido]acetamido}hexanoic acid

Cys Val Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylbutanamido]hexanamido]acetic acid

Gly Ala Lys Met

(2S)-2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)propanamido]hexanamido]-4-(methylsulfanyl)butanoic acid

Gly Ala Met Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-4-(methylsulfanyl)butanamido]hexanoic acid

Gly Cys Lys Val

(2S)-2-[(2S)-6-amino-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]hexanamido]-3-methylbutanoic acid

Gly Cys Val Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-methylbutanamido]hexanoic acid

Gly Lys Ala Met

(2S)-2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]propanamido]-4-(methylsulfanyl)butanoic acid

Gly Lys Cys Val

(2S)-2-[(2R)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-sulfanylpropanamido]-3-methylbutanoic acid

Gly Lys Met Ala

(2S)-2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-4-(methylsulfanyl)butanamido]propanoic acid

Gly Lys Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

Gly Lys Val Cys

(2R)-2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-methylbutanamido]-3-sulfanylpropanoic acid

Gly Met Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-(methylsulfanyl)butanamido]propanamido]hexanoic acid

Gly Met Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-4-(methylsulfanyl)butanamido]hexanamido]propanoic acid

Gly Arg Ser Ser

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

Gly Ser Arg Ser

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanoic acid

Gly Ser Ser Arg

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanoic acid

Gly Thr Lys Thr

(2S,3R)-2-[(2S)-6-amino-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]hexanamido]-3-hydroxybutanoic acid

Gly Thr Thr Lys

(2S)-6-amino-2-[(2S,3R)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-3-hydroxybutanamido]hexanoic acid

Gly Val Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]-3-sulfanylpropanamido]hexanoic acid

Gly Val Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]hexanamido]-3-sulfanylpropanoic acid

Lys Cys Arg

Gln Lys Met

Lys Arg Cys

Lys Ala Gly Met

(2S)-2-{2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]acetamido}-4-(methylsulfanyl)butanoic acid

Lys Ala Met Gly

2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-4-(methylsulfanyl)butanamido]acetic acid

Lys Ala Ser Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

Lys Ala Thr Ser

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

Lys Cys Gly Val

(2S)-2-{2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]acetamido}-3-methylbutanoic acid

Lys Cys Val Gly

2-[(2S)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-3-methylbutanamido]acetic acid

Cys Lys Arg

Arg Cys Lys

Lys Gly Ala Met

(2S)-2-[(2S)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}propanamido]-4-(methylsulfanyl)butanoic acid

Lys Gly Cys Val

(2S)-2-[(2R)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-sulfanylpropanamido]-3-methylbutanoic acid

Lys Gly Met Ala

(2S)-2-[(2S)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-4-(methylsulfanyl)butanamido]propanoic acid

Lys Gly Thr Thr

(2S,3R)-2-[(2S,3R)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-hydroxybutanamido]-3-hydroxybutanoic acid

Lys Gly Val Cys

(2R)-2-[(2S)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-methylbutanamido]-3-sulfanylpropanoic acid

Lys Gln Met

Lys Met Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-(methylsulfanyl)butanamido]propanamido]acetic acid

Lys Met Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-(methylsulfanyl)butanamido]acetamido}propanoic acid

Lys Ser Ala Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]propanamido]-3-hydroxybutanoic acid

Lys Ser Thr Ala

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]propanoic acid

Lys Thr Ala Ser

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxybutanamido]propanamido]-3-hydroxypropanoic acid

Lys Thr Gly Thr

(2S,3R)-2-{2-[(2S,3R)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxybutanamido]acetamido}-3-hydroxybutanoic acid

Lys Thr Ser Ala

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]propanoic acid

Lys Thr Thr Gly

2-[(2S,3R)-2-[(2S,3R)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]acetic acid

Lys Val Cys Gly

2-[(2R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]-3-sulfanylpropanamido]acetic acid

Lys Val Gly Cys

(2R)-2-{2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]acetamido}-3-sulfanylpropanoic acid

Gln Met Lys

Lys Met Gln

Met Ala Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]propanamido]acetamido}hexanoic acid

Met Ala Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]propanamido]hexanamido]acetic acid

Met Gly Ala Lys

(2S)-6-amino-2-[(2S)-2-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetamido}propanamido]hexanoic acid

Met Gly Lys Ala

(2S)-2-[(2S)-6-amino-2-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetamido}hexanamido]propanoic acid

His His Leu

Met Lys Ala Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]hexanamido]propanamido]acetic acid

Met Lys Gly Ala

(2S)-2-{2-[(2S)-6-amino-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]hexanamido]acetamido}propanoic acid

Cys Arg Lys

Arg Lys Cys

C17H35N5O4S1 (405.2409630000001)

Lys Lys Met

Met Lys Gln

His Leu His

Leu His His

Arg Gly Ser Ser

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}-3-hydroxypropanamido]-3-hydroxypropanoic acid

Arg Ser Gly Ser

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanamido]acetamido}-3-hydroxypropanoic acid

Arg Ser Ser Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]acetic acid

Ser Ala Lys Thr

(2S,3R)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]hexanamido]-3-hydroxybutanoic acid

Ser Ala Thr Lys

(2S)-6-amino-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-3-hydroxybutanamido]hexanoic acid

Ser Gly Arg Ser

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-5-carbamimidamidopentanamido]-3-hydroxypropanoic acid

Ser Gly Ser Arg

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-hydroxypropanamido]-5-carbamimidamidopentanoic acid

Ser Lys Ala Thr

(2S,3R)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]propanamido]-3-hydroxybutanoic acid

Ser Lys Thr Ala

(2S)-2-[(2S,3R)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]-3-hydroxybutanamido]propanoic acid

C17H35N5O4S1 (405.2409630000001)

Met Lys Lys

Ser Arg Gly Ser

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanamido]acetamido}-3-hydroxypropanoic acid

Ser Arg Ser Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanamido]acetic acid

Ser Ser Gly Arg

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]acetamido}-5-carbamimidamidopentanoic acid

Ser Ser Arg Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanamido]acetic acid

Met Gln Lys

Ser Thr Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]propanamido]hexanoic acid

Ser Thr Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]hexanamido]propanoic acid

Thr Ala Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanamido]hexanamido]-3-hydroxypropanoic acid

Thr Ala Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanamido]-3-hydroxypropanamido]hexanoic acid

C17H35N5O4S1 (405.2409630000001)

Lys Met Lys

Thr Gly Lys Thr

(2S,3R)-2-[(2S)-6-amino-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}hexanamido]-3-hydroxybutanoic acid

Thr Gly Thr Lys

(2S)-6-amino-2-[(2S,3R)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}-3-hydroxybutanamido]hexanoic acid

Thr Lys Ala Ser

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S,3R)-2-amino-3-hydroxybutanamido]hexanamido]propanamido]-3-hydroxypropanoic acid

Thr Lys Gly Thr

(2S,3R)-2-{2-[(2S)-6-amino-2-[(2S,3R)-2-amino-3-hydroxybutanamido]hexanamido]acetamido}-3-hydroxybutanoic acid

Thr Lys Ser Ala

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S,3R)-2-amino-3-hydroxybutanamido]hexanamido]-3-hydroxypropanamido]propanoic acid

Thr Lys Thr Gly

2-[(2S,3R)-2-[(2S)-6-amino-2-[(2S,3R)-2-amino-3-hydroxybutanamido]hexanamido]-3-hydroxybutanamido]acetic acid

Thr Ser Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]propanamido]hexanoic acid

Thr Ser Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]hexanamido]propanoic acid

Thr Thr Gly Lys

(2S)-6-amino-2-{2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]acetamido}hexanoic acid

Thr Thr Lys Gly

2-[(2S)-6-amino-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]hexanamido]acetic acid

Val Cys Gly Lys

(2S)-6-amino-2-{2-[(2R)-2-[(2S)-2-amino-3-methylbutanamido]-3-sulfanylpropanamido]acetamido}hexanoic acid

Val Cys Lys Gly

2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-amino-3-methylbutanamido]-3-sulfanylpropanamido]hexanamido]acetic acid

Val Gly Cys Lys

(2S)-6-amino-2-[(2R)-2-{2-[(2S)-2-amino-3-methylbutanamido]acetamido}-3-sulfanylpropanamido]hexanoic acid

Val Gly Lys Cys

(2R)-2-[(2S)-6-amino-2-{2-[(2S)-2-amino-3-methylbutanamido]acetamido}hexanamido]-3-sulfanylpropanoic acid

Val Lys Cys Gly

2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]-3-sulfanylpropanamido]acetic acid

Val Lys Gly Cys

(2R)-2-{2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]acetamido}-3-sulfanylpropanoic acid

1,2-Diphenyl-1-[4-[2-(dimethylamino)ethoxy]phenyl]butane-1,4-diol

C24H36ClNO2 (405.24344260000004)

1-[4-(1-ADAMANTYL)PHENOXY]-3-PIPERIDINOPROPAN-2-OL HYDROCHLORIDE

Piboserod (hydrochloride)

C22H32ClN3O2 (405.2182922)

Befiperide

Urea, N-cyclohexyl-N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(3-pyridinylmethyl)- (9CI)

C24H31N5O (405.2528476)

3,5-Dibenzyloxy terbutalline

cinpropazide

Bis[4-(2-phenyl-2-propyl)phenyl]amine

C30H31N (405.2456366)

neodecanoic acid, copper salt

C20H38CuO4 (405.2065938)

Methyl (2S)-2-[(tert-butoxycarbonyl)amino]-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propanoate

C21H32BNO6 (405.2322562)

potassium: 1,2-diethenylbenzene: 1-ethenyl-2-ethyl-benzene: styrene

C28H30K+ (405.198446)

4-Oxofenretinide

D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids

2(S)-ACETYLTHIO-BENZENEPROPANOIC ACID N-CYCLOHEXYLCYCLOHEXANAMINE

C21H26F3N5 (405.21401920000005)

Lorpiprazole

(S)-METHYL 2-((TERT-BUTOXYCARBONYL)AMINO)-3-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)PROPANOATE

C21H32BNO6 (405.2322562)

Bencyclane fumarate

3-(1-benzylcycloheptyl)oxy-N,N-dimethylpropan-1-amine,(E)-but-2-enedioic acid

C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

1H-Indole-1-carboxylic acid, 2-borono-6-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-, 1-(1,1-dimethylethyl) ester (9CI)

C20H32BNO5Si (405.2142692)

1H-Indole-1-carboxylic acid, 2-borono-5-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-, 1,1-dimethylethyl ester

C20H32BNO5Si (405.2142692)

4-(N-Ethyl-N-benzyl)amino benzoaldehyde-1,1-diphenylhydrazone

C28H27N3 (405.22048620000004)

2(r)-acetylthio-benzenepropanoic acid n-cyclohexylcyclohexanamine

Neotuberostemone

Terbogrel

C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent C471 - Enzyme Inhibitor

1-(4-TRANS-HEXYLCYCLOHEXYL)-4-(2-(4-ISO&

C27H35NS (405.24900700000006)

DIETHYL 1,4-DIHYDRO-2,6-DIMETHYL-1,4-DIPHENYL-3,5-PYRIDINEDICARBOXYLATE

8-Cyclopentyl-5-methyl-2-{[5-(1-piperazinyl)-2-pyridinyl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one

C22H19D6NO6 (405.20584206800004)

Colchicine-d6

3-[(1R)-3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-hydroxy-benzoic acid methyl ester hydrochloride (1:1)

C23H31NO3.HCl (405.20705920000006)

Carbamic acid, N-[(1S)-1-[[[(1S)-1-(hydroxymethyl)-2-(2-oxo-3-pyrrolidinyl)ethyl]amino]carbonyl]-3-methylbutyl]-, phenylmethyl ester

N-Fmoc-2-amino-2-(3-butenyl)hex-5-enoic acid

Fortimicin A

1-isopropyl-1-(2-methyl-1H-benzo[d]imidazole-6-carbonyl)-4,6-dihydrospiro[indazole-5,4-piperidin]-7(1H)-one

PF-05175157 is broad spectrum acetyl-CoA carboxylase (ACC) inhibitor with IC50s of 27.0, 33.0, 23.5 and 50.4 nM for ACC1 (human), ACC2 (human), ACC1 (rat), ACC2 (rat), respectively.

N-(4-Methoxyphenyl)-all-trans-retinamide

C20H40NO5P (405.2643960000001)

D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids

Naepa

Celacinnine

A spermidine alkaloid that is isolated from Maytenus heterophylla and Maytenus senegalensis.

2-Mpmdq

2-[trans-(4-Aminocyclohexyl)amino]-6-(benzyl-amino)-9-cyclopentylpurine

C23H31N7 (405.2640806)

N-(1-Isopropylpiperidin-4-YL)-1-(3-methoxybenzyl)-1H-indole-2-carboxamide

C21H35N5O3 (405.27397600000006)

N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide

3alpha,7alpha-Dihydroxy-12-oxo-5beta-cholanate

D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

3alpha,12alpha-Dihydroxy-7-oxo-5beta-cholanate

7alpha,12alpha-Dihydroxy-3-oxo-5beta-cholan-24-Oate

A bile acid anion that is the conjugate base of 7alpha,12alpha-dihydroxy-3-oxo-5beta-cholan-24-oic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid

(Z)-6-[3-[(N-tert-butyl-N-cyanocarbamimidoyl)amino]phenyl]-6-pyridin-3-ylhex-5-enoic acid

N-Eicosapentaenoyl Cysteine

Ancistrotanzanine A

An isoquinoline alkaloid that is (3S)-6,8-dimethoxy-1,3-dimethyl-3,4-dihydroisoquinoline substituted by a 1-hydroxy-8-methoxy-3-methylnaphthalen-2-yl group at position 5. It is isolated from the leaves of Ancistrocladus tanzaniensis and exhibits antiplasmodial, antileishmanial and antitrypanocidal activities.

Endiandramide A

A natural product found in Beilschmiedia tsangii.

1-[4-(9-Benzylfluoren-9-yl)but-2-ynyl]azepane

C30H31N (405.2456366)

D002317 - Cardiovascular Agents > D026902 - Potassium Channel Blockers D049990 - Membrane Transport Modulators

22alpha,23alpha-Epoxy-solanida-1,4,9-trien-3-one

A natural product found in Solanum campaniforme.

(2S)-Hydroxy-(11S,12R)-dihydrostemofoline, (rel)-

A natural product found in Stemona aphylla.

Lys-Met-Lys

Stemocurtisinol

A natural product found in Stemona curtisii.

Oxystemokerrine

C27H25N4+ (405.20791099999997)

A natural product found particularly in Stemona and Stemona curtisii.

mauveine B

mauveine B2

C27H25N4+ (405.20791099999997)

His-His-Leu

Talathermophilins B

A natural product found in Talaromyces thermophilus and Talaromyces thermophilus.

2-[[4-amino-6-(2-methylanilino)-1,3,5-triazin-2-yl]methyl-methylamino]-N-(2-ethylphenyl)acetamide

4-[4-[(1-Cyclopentyl-5-tetrazolyl)-pyridin-4-ylmethyl]-1-piperazinyl]phenol

2-[(2-hydroxy-1-naphthalenyl)methyl-methylamino]-N-[4-(4-morpholinyl)phenyl]acetamide

N-[2-[1-[2-(4-methylphenoxy)ethyl]-2-benzimidazolyl]ethyl]cyclohexanecarboxamide

4-[[3-(Diethylamino)propylamino]methylidene]-2-(2,6-dimethylphenyl)isoquinoline-1,3-dione

4-[(1-cyclopentyl-5-tetrazolyl)-(3,4-dihydro-1H-isoquinolin-2-yl)methyl]-2-methoxyphenol

3alpha,7beta-Dihydroxy-12-oxo-5beta-cholanate

N-[2-(3,4-diethoxyphenyl)ethyl]-4-phenoxybenzamide

His-Leu-His

2-(4-Chlorophenyl)-3-(4-fluorophenyl)-1-(4-morpholinyl)-3-heptanol

C23H29ClFNO2 (405.1870736)

1-[(2S,3S,6S)-6-[2-[4-(3-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propylurea

1-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3-oxanyl]-3-(3-methoxyphenyl)urea

1-[(2S,3R,6S)-6-[2-[4-(3-fluorophenyl)triazol-1-yl]ethyl]-2-(hydroxymethyl)oxan-3-yl]-3-propylurea

1-[(2R,3S,6S)-6-[2-[4-(3-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propylurea

1-[(2S,3S,6R)-6-[2-[4-(3-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propylurea

1-[(2R,3S,6R)-2-(hydroxymethyl)-6-(2-oxo-2-piperidin-1-ylethyl)oxan-3-yl]-3-(3-methoxyphenyl)urea

1-[(2S,3R,6R)-2-(hydroxymethyl)-6-(2-oxo-2-piperidin-1-ylethyl)oxan-3-yl]-3-(3-methoxyphenyl)urea

N-[(4S,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5R,6R,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5R,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5R,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

1-[(2S,3R,6R)-6-[2-[4-(3-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propylurea

1-[(2R,3R,6S)-6-[2-[4-(3-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propylurea

1-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3-oxanyl]-3-(3-methoxyphenyl)urea

1-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3-oxanyl]-3-(3-methoxyphenyl)urea

1-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3-oxanyl]-3-(3-methoxyphenyl)urea

N-[2-[(2R,5S,6R)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]cyclopropanecarboxamide

N-[2-[(2S,5S,6R)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]cyclopropanecarboxamide

1-(2-fluorophenyl)-3-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-(4-propyl-1-triazolyl)ethyl]-3-oxanyl]urea

1-(2-fluorophenyl)-3-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-(4-propyl-1-triazolyl)ethyl]-3-oxanyl]urea

1-(2-fluorophenyl)-3-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-(4-propyl-1-triazolyl)ethyl]-3-oxanyl]urea

1-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]-3-(3-methoxyphenyl)urea

1-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]-3-(3-methoxyphenyl)urea

1-[(2R,3R,6S)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propan-2-ylurea

1-[(2S,3S,6S)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propan-2-ylurea

1-[(2R,3S,6S)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propan-2-ylurea

1-[(8R,9S,10S)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]-2-pyridin-3-ylethanone

1-[(8R,9S,10R)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]-2-pyridin-3-ylethanone

1-[(8R,9R,10S)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]-2-pyridin-3-ylethanone

[(8S,9R,10S)-9-[4-(3-methoxyprop-1-ynyl)phenyl]-6-(pyridin-4-ylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

[(8S,9S,10R)-9-[4-(3-methoxyprop-1-ynyl)phenyl]-6-(pyridin-4-ylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

N-[(4R,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4R,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4R,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5S,6S,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5S,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5S,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

1-[(2R,3S,6R)-6-[2-[4-(3-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propylurea

1-[(2R,3R,6R)-6-[2-[4-(3-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propylurea

1-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3-oxanyl]-3-(3-methoxyphenyl)urea

1-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3-oxanyl]-3-(3-methoxyphenyl)urea

N-[2-[(2S,5R,6S)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]cyclopropanecarboxamide

N-[2-[(2R,5R,6S)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]cyclopropanecarboxamide

N-[2-[(2R,5R,6R)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]cyclopropanecarboxamide

N-[2-[(2R,5S,6S)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]cyclopropanecarboxamide

N-[2-[(2S,5S,6S)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]cyclopropanecarboxamide

N-[2-[(2S,5R,6R)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]cyclopropanecarboxamide

1-(2-fluorophenyl)-3-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-(4-propyl-1-triazolyl)ethyl]-3-oxanyl]urea

1-(2-fluorophenyl)-3-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-(4-propyl-1-triazolyl)ethyl]-3-oxanyl]urea

1-(2-fluorophenyl)-3-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-(4-propyl-1-triazolyl)ethyl]-3-oxanyl]urea

1-(2-fluorophenyl)-3-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-(4-propyl-1-triazolyl)ethyl]-3-oxanyl]urea

1-(2-fluorophenyl)-3-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-(4-propyl-1-triazolyl)ethyl]-3-oxanyl]urea

1-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]-3-(3-methoxyphenyl)urea

1-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]-3-(3-methoxyphenyl)urea

1-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]-3-(3-methoxyphenyl)urea

1-[(2S,3R,6S)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propan-2-ylurea

1-[(2R,3S,6R)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propan-2-ylurea

1-[(2S,3R,6R)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propan-2-ylurea

1-[(2R,3R,6R)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propan-2-ylurea

1-[(2S,3S,6R)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-propan-2-ylurea

1-[(8S,9R,10R)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]-2-pyridin-3-ylethanone

1-[(8S,9R,10S)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]-2-pyridin-3-ylethanone

1-[(8R,9R,10R)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]-2-pyridin-3-ylethanone

1-[(8S,9S,10S)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]-2-pyridin-3-ylethanone

1-[(8S,9S,10R)-10-(hydroxymethyl)-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]-2-pyridin-3-ylethanone

[(8R,9S,10R)-9-[4-(3-methoxyprop-1-ynyl)phenyl]-6-(pyridin-4-ylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

[(8S,9S,10S)-9-[4-(3-methoxyprop-1-ynyl)phenyl]-6-(pyridin-4-ylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

[(8R,9R,10R)-9-[4-(3-methoxyprop-1-ynyl)phenyl]-6-(pyridin-4-ylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

1-[(1R)-1-(hydroxymethyl)-7-methoxy-1-methyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-2-phenylethanone

1-[(1S)-1-(hydroxymethyl)-7-methoxy-1-methyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-2-phenylethanone

[(1R)-1-(hydroxymethyl)-7-methoxy-1-spiro[1,2,3,9-tetrahydropyrido[3,4-b]indole-4,4-piperidine]yl]-phenylmethanone

[(1S)-1-(hydroxymethyl)-7-methoxy-1-spiro[1,2,3,9-tetrahydropyrido[3,4-b]indole-4,4-piperidine]yl]-phenylmethanone

Cys-Lys-Arg

Lys-Gln-Met

Lys-Met-Gln

Met-Gln-Lys

Met-Lys-Lys

Eliglustat(1+)

C23H37N2O4+ (405.2753182)

Leu-His-His

Arg-Cys-Lys

Arg-Lys-Cys

Cys-Arg-Lys

Gln-Lys-Met

Gln-Met-Lys

His-His-Ile

His-Ile-His

Ile-His-His

Lys-Arg-Cys

Lys-Cys-Arg

Lys-Lys-Met

Met-Lys-Gln

HexCer 9:1;2O/4:0

HexCer 8:1;2O/5:0

Ldgcc 10:0

C20H39NO7 (405.2726384)

HexCer 11:1;2O/2:0

HexCer 10:1;2O/3:0

C20H39NO5S (405.25488040000005)

(E)-2-(decanoylamino)-3-hydroxydec-4-ene-1-sulfonic acid

trequinsin

C20H40NO5P (405.2643960000001)

D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor

SPHP(20:2)

SPHP(d20:2)

NA-Cys 20:5(5Z,8Z,11Z,14Z,17Z)

NA-DOPA 14:1(9Z)

NA-Glu 18:4(6Z,9Z,12Z,15Z)

MGCC 10:0

C20H39NO7 (405.2726384)

ST 20:3;O4;Gly

ST 21:2;O3;Gly

Rac1-IN-3

C21H23N7O2 (405.1913138)

Rac1-IN-3 (Compound 2) is a Rac1 inhibitor with an IC50 of 46.1 μM[1].

(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-3-(3h-imidazol-4-yl)propylidene]amino}-1-hydroxy-3-(3h-imidazol-4-yl)propylidene]amino}-4-methylpentanoic acid

(1s,2r,3s,10s,11r)-11-[(1s)-1-hydroxypropyl]-4-[(2z)-3-methoxy-4-methyl-5-oxofuran-2-ylidene]-3-methyl-5-oxa-10-azatricyclo[8.4.0.0²,⁶]tetradec-6-en-10-ium-10-olate

(1s,2r,3r,6s,7s,8s,10s)-2-ethyl-8-hydroxy-6-methyl-10-[(2s,4r)-4-methyl-5-oxooxolan-2-yl]-4-oxa-11-azatetracyclo[9.4.1.0¹,⁸.0³,⁷]hexadecane-5,16-dione

14-ethyl-9-methoxy-4,6,17-trioxa-14-azaoctacyclo[10.8.2.1²,⁸.0¹,¹³.0³,⁷.0³,¹¹.0¹⁶,¹⁸.0¹⁶,²¹]tricosane-11,20-diol

(1s,2s,3s,6s,7r,8s,10r,15r)-2-ethyl-15-hydroxy-6-methyl-10-[(2r,4r)-4-methyl-5-oxooxolan-2-yl]-4-oxa-11-azatetracyclo[9.4.1.0¹,⁸.0³,⁷]hexadecane-5,16-dione

5-[(1r,6s,9r,10r,11r,12s,13e)-6-[(1s)-1-hydroxypropyl]-12-methyl-14,15-dioxa-5-azatetracyclo[7.5.1.0¹,¹¹.0⁵,¹⁰]pentadecan-13-ylidene]-4-methoxy-3-methylfuran-2-one

(2e)-1-[(6s)-8-hydroxy-6-phenyl-1,5,9-triazacyclotridec-8-en-1-yl]-3-phenylprop-2-en-1-one

5-[(1r,6s,9r,10r,11r,12s)-6-[(1s)-1-hydroxypropyl]-12-methyl-14,15-dioxa-5-azatetracyclo[7.5.1.0¹,¹¹.0⁵,¹⁰]pentadecan-13-ylidene]-4-methoxy-3-methylfuran-2-one

2-[(3r)-6,8-dimethoxy-1,3-dimethyl-3,4-dihydroisoquinolin-7-yl]-8-methoxy-3-methylnaphthalen-1-ol

3-hydroxy-n-(3-hydroxy-1-methoxy-1-oxobutan-2-yl)-2-methyl-2-(4-methylpent-3-en-1-yl)-3,4-dihydro-1-benzopyran-6-carboximidic acid

(2r,3s)-3-hydroxy-n-[(2s,3r)-3-hydroxy-1-methoxy-1-oxobutan-2-yl]-2-methyl-2-(4-methylpent-3-en-1-yl)-3,4-dihydro-1-benzopyran-6-carboximidic acid

1-(2-hydroxypropyl)-2-methyl-6-[(2,4,4-trimethylcyclohex-1-en-1-yl)methyl]-9h-carbazole-3,4-dione

2-(6,8-dimethoxy-1,3-dimethyl-3,4-dihydroisoquinolin-5-yl)-8-methoxy-3-methylnaphthalen-1-ol

(3s)-5-(4,5-dimethoxy-2-methylnaphthalen-1-yl)-8-methoxy-1,3-dimethyl-3,4-dihydroisoquinolin-6-ol

11-ethyl-8,16-dihydroxy-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-one

(1r,2r,3s,6s,7s,10s)-2-ethyl-6-methyl-10-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]-4-oxa-11-azatricyclo[9.4.1.0³,⁷]hexadecane-5,8,16-trione

(1s,2s,3s,6s,7s,8r,10s)-2-ethyl-8-hydroxy-6-methyl-10-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]-4-oxa-11-azatetracyclo[9.4.1.0¹,⁸.0³,⁷]hexadecane-5,16-dione

5-[6-(1-hydroxypropyl)-12-methyl-14,15-dioxa-5-azatetracyclo[7.5.1.0¹,¹¹.0⁵,¹⁰]pentadecan-13-ylidene]-4-methoxy-3-methylfuran-2-one

(2z)-1-(6-hydroxy-8-phenyl-1,5,9-triazacyclotridec-5-en-1-yl)-3-phenylprop-2-en-1-one

akirine

{"Ingredient_id": "HBIN015020","Ingredient_name": "akirine","Alias": "NA","Ingredient_formula": "C22H31NO6","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7069","PubChem_id": "NA","DrugBank_id": "NA"}

ancistrobarterine a

{"Ingredient_id": "HBIN015982","Ingredient_name": "ancistrobarterine a","Alias": "NA","Ingredient_formula": "C25H27NO4","Ingredient_Smile": "CC1CC2=CC(=C(C(=C2C(=N1)C)OC)C3=C4C=CC=C(C4=C(C=C3C)OC)OC)O","Ingredient_weight": "405.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "21539","PubChem_id": "135457480","DrugBank_id": "NA"}

ancistrocladidine